Arbutus Biopharma Corporation (ABUS)
Market Closed
17 Jul, 20:00
$
4. 56
-0.18
-3.7975%
$
910.65M Market Cap
- P/E Ratio
- Div Yield
1.6M Volume
-0.45 Eps
$ 4.74
Previous Close 
Want to track ABUS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Arbutus Biopharma Corporation (ABUS) Statistics
Valuation metrics
Market Cap 910.65M
Enterprise value 880.97M
Trailing P/E (ttm) 5.47
Forward P/E -
PEG ratio 0
Price/Sales (ttm) 4.71
Price/Book (mrq) 3.4
Enterprise Value/Revenue 4.6
Enterprise Value/EBITDA 5.48
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 2M
Average volume (90 days) 1.94M
Price summary
52-Week low 3.08
52-Week high 5.38
Beta -
50-Day moving average 4.52
200-Day moving average 4.4
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:5
Last split Date 4 Nov 2010
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.84%
Operating margin 0.81%
Operational effectiveness
Return on assets 0.58%
Return on equity 1.29%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.99
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 0.83
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.49
Total debt (mrq) -
Total Debt/Equity (mrq) 0.02
Current ratio (mrq) 54.26%
Book value per share (mrq) 1.34
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
